LGALS4 and gastric cancer: Experimental silencing or knockout of Gal-4 in gastric cancer models has been shown to reduce the levels of activated c-MET and CD44, leading to attenuated cell proliferation and decreased peritoneal dissemination (Figure 6) [169].